chr22-31619756-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2
The NM_001326411.2(PISD):c.1086C>T(p.Gly362Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000349 in 1,614,170 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00022 ( 3 hom. )
Consequence
PISD
NM_001326411.2 synonymous
NM_001326411.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.123
Genes affected
PISD (HGNC:8999): (phosphatidylserine decarboxylase) The protein encoded by this gene catalyzes the conversion of phosphatidylserine to phosphatidylethanolamine in the inner mitochondrial membrane. The encoded protein is active in phospholipid metabolism and interorganelle trafficking of phosphatidylserine. [provided by RefSeq, May 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.074).
BP6
Variant 22-31619756-G-A is Benign according to our data. Variant chr22-31619756-G-A is described in ClinVar as [Benign]. Clinvar id is 1600129.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.123 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00157 (239/152356) while in subpopulation AFR AF = 0.00541 (225/41572). AF 95% confidence interval is 0.00483. There are 0 homozygotes in GnomAd4. There are 108 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00157 AC: 239AN: 152238Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
239
AN:
152238
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000510 AC: 128AN: 251078 AF XY: 0.000368 show subpopulations
GnomAD2 exomes
AF:
AC:
128
AN:
251078
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000222 AC: 325AN: 1461814Hom.: 3 Cov.: 32 AF XY: 0.000184 AC XY: 134AN XY: 727218 show subpopulations
GnomAD4 exome
AF:
AC:
325
AN:
1461814
Hom.:
Cov.:
32
AF XY:
AC XY:
134
AN XY:
727218
Gnomad4 AFR exome
AF:
AC:
197
AN:
33478
Gnomad4 AMR exome
AF:
AC:
24
AN:
44722
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26134
Gnomad4 EAS exome
AF:
AC:
3
AN:
39700
Gnomad4 SAS exome
AF:
AC:
8
AN:
86256
Gnomad4 FIN exome
AF:
AC:
0
AN:
53416
Gnomad4 NFE exome
AF:
AC:
44
AN:
1111944
Gnomad4 Remaining exome
AF:
AC:
47
AN:
60396
Heterozygous variant carriers
0
17
35
52
70
87
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00157 AC: 239AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.00145 AC XY: 108AN XY: 74502 show subpopulations
GnomAD4 genome
AF:
AC:
239
AN:
152356
Hom.:
Cov.:
33
AF XY:
AC XY:
108
AN XY:
74502
Gnomad4 AFR
AF:
AC:
0.0054123
AN:
0.0054123
Gnomad4 AMR
AF:
AC:
0.000522534
AN:
0.000522534
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000146977
AN:
0.0000146977
Gnomad4 OTH
AF:
AC:
0.00189215
AN:
0.00189215
Heterozygous variant carriers
0
13
26
40
53
66
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at